# Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod

> **NCT01790269** · — · TERMINATED · sponsor: **Charite University, Berlin, Germany** · enrollment: 21 (actual)

## Conditions studied

- Relapsing-Remitting Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01790269
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01790269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01790269, "Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01790269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*